• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Marksans Pharma Ltd

+ Add to Watchlist

MRKS:IN

61.95 INR 0.10 0.16%

As of 06:06:11 ET on 12/29/2014.

Snapshot for Marksans Pharma Ltd (MRKS)

Open: 62.55 Day's Range: 61.50 - 63.75 Volume: 1,776,874
Previous Close: 62.05 52wk Range: 14.60 - 69.35 1-Yr Rtn: +223.16%

Stock Chart for MRKS

No chart data available.
  • MRKS:IN 61.95
  • 1D
  • 1M
  • 1Y
62.05
Interactive MRKS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRKS

Current P/E Ratio (ttm) 33.1283
Estimated P/E(03/2015) 21.8134
Relative P/E vs. SENSEX 1.7458
Earnings Per Share (INR) (ttm) 1.8700
Est. EPS (INR) (03/2015) 2.8400
Est. PEG Ratio -
Market Cap (M INR) 23,869.78
Shares Outstanding (M) 385.31
30 Day Average Volume 3,560,898
Price/Book (mrq) 18.5494
Price/Sale (ttm) 3.7980
Dividend Indicated Gross Yield 0.16%
Cash Dividend (INR) 0.1000
Dividend Ex-Date 09/18/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRKS

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for MRKS

Marksans Pharma Limited manufactures active ingredients that are used to produce finished drugs.

Mark SaldanhaChairman/Managing DirectorBalwant Shankarrao DesaiChief Operating Officer
Sandra SaldanhaExecutive DirectorJitendra M SharmaChief Financial Officer
More Company Profile & Key Executives for MRKS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil